Article info

Download PDFPDF

HbA1c as a predictor for response of bevacizumab in diabetic macular oedema

Authors

  1. Correspondence to Dr Sadhana Sharma; ssadnaa{at}gmail.com
View Full Text

Citation

Sharma S, Joshi SN, Karki P
HbA1c as a predictor for response of bevacizumab in diabetic macular oedema

Publication history

  • Received March 10, 2020
  • Revised April 21, 2020
  • Accepted April 30, 2020
  • First published May 12, 2020.
Online issue publication 
May 12, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.